Renaissance Technologies’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.56M | Buy |
1,093,188
+878,688
| +410% | +$1.26M | ﹤0.01% | 2265 |
|
|
2025
Q1 | $343K | Buy |
+214,500
| New | +$343K | ﹤0.01% | 2879 |
|
|
2024
Q3 | – | Sell |
-235,200
| Closed | -$1.09M | – | 3553 |
|
|
2024
Q2 | $1.09M | Sell |
235,200
-170,600
| -42% | -$788K | ﹤0.01% | 2273 |
|
|
2024
Q1 | $3.32M | Sell |
405,800
-18,900
| -4% | -$154K | 0.01% | 1691 |
|
|
2023
Q4 | $2.4M | Buy |
424,700
+66,712
| +19% | +$377K | ﹤0.01% | 1842 |
|
|
2023
Q3 | $666K | Sell |
357,988
-158,910
| -31% | -$296K | ﹤0.01% | 2568 |
|
|
2023
Q2 | $1.42M | Buy |
516,898
+190,818
| +59% | +$525K | ﹤0.01% | 2220 |
|
|
2023
Q1 | $1.02M | Buy |
326,080
+293,580
| +903% | +$922K | ﹤0.01% | 2468 |
|
|
2022
Q4 | $192K | Sell |
32,500
-30,300
| -48% | -$179K | ﹤0.01% | 3435 |
|
|
2022
Q3 | $551K | Buy |
62,800
+51,300
| +446% | +$450K | ﹤0.01% | 2877 |
|
|
2022
Q2 | $87K | Buy |
+11,500
| New | +$87K | ﹤0.01% | 3882 |
|
|
2022
Q1 | – | Sell |
-31,300
| Closed | -$1.01M | – | 4098 |
|
|
2021
Q4 | $1.01M | Buy |
+31,300
| New | +$1.01M | ﹤0.01% | 2631 |
|